International Stem Cell (ISCO) Other financing activities (2013 - 2018)
International Stem Cell (ISCO) posted quarterly Other financing activities of $15000.0 for Q4 2018, down 28.57% quarter-over-quarter from $21000.0 in Q3 2018.
International Stem Cell (ISCO) Other financing activities (2013 - 2018) Analysis & Trends
International Stem Cell (ISCO) has reported Other financing activities for 4 consecutive years, with $15000.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Other financing activities changed N/A year-over-year to $15000.0; the TTM figure through Dec 2018 stood at $160000.0 (changed N/A YoY), while the FY2018 annual figure was $160000.0, changed N/A from the prior year.
- Other financing activities slipped to $15000.0 in Q4 2018 per ISCO's latest filing, from $21000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $567000.0 in Q4 2015 and bottomed at $15000.0 in Q4 2018.
- Historically, Other financing activities has averaged $254125.0 across 3 years, with a median of $233000.0 in 2016.
- On a YoY basis, Other financing activities climbed as much as 11.99% in 2016 and fell as far as 11.99% in 2016.
- International Stem Cell's Other financing activities stood at $567000.0 in 2015, then fell by 11.99% to $499000.0 in 2016, then plunged by 96.99% to $15000.0 in 2018.
- Business Quant data shows ISCO's Other financing activities at $15000.0 in Q4 2018, $21000.0 in Q3 2018, and $34000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 15,000.00 |
| Dec 31, 2018 | 15,000.00 |
| Sep 30, 2018 | 21,000.00 |
| Sep 30, 2018 | 21,000.00 |
| Jun 30, 2018 | 34,000.00 |
| Jun 30, 2018 | 34,000.00 |
| Mar 31, 2018 | 90,000.00 |
| Mar 31, 2018 | 90,000.00 |
| Dec 31, 2016 | 499,000.00 |
| Dec 31, 2016 | 499,000.00 |
| Jun 30, 2016 | 376,000.00 |
| Jun 30, 2016 | 376,000.00 |
| Dec 31, 2015 | 567,000.00 |
| Dec 31, 2015 | 567,000.00 |
| Mar 31, 2015 | 431,000.00 |
| Mar 31, 2015 | 431,000.00 |
| Dec 31, 2013 | 2.14 Mn |
| Dec 31, 2013 | 2.14 Mn |